In a model of Parkinson’s disease (PD), Nox4 expression was significantly upregulated in the midbrain periaqueductal gray, and blocking Nox4 in this area by infusion of the Nox4 inhibitor GKT137831 resulted in decreased oxidative stress and blunted mechanical and thermal pain responses. This evidence concerns the gene NOX4 and Parkinson disease.